middle.news
Why Is Nyrada Testing Higher Doses and Longer Infusions of Xolatryp?
11:11am on Wednesday 4th of June, 2025 AEST
•
Biotechnology
Read Story
Why Is Nyrada Testing Higher Doses and Longer Infusions of Xolatryp?
11:11am on Wednesday 4th of June, 2025 AEST
Key Points
Human Research Ethics Committee approves Phase I protocol amendment
Higher dosage and longer infusion duration to be tested for Xolatryp
Phase I trial expanded to six cohorts with ongoing safety assessments
Preclinical studies show promising neuro- and cardioprotective effects
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nyrada (ASX:NYR)
OPEN ARTICLE